Wilson Therapeutics Company

Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Technology: Cancer
Industry: PharmTech
Headquarters: Stockholm, Stockholms Lan, Sweden
Founded Date: 2012
Employees Number: 11-50
Funding Status: M&A
Investors Number: 2
Total Funding: $27.2M
Estimated Revenue: $10M to $50M
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership